New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.

While it found that global uptake of at least one COVID-19 vaccine dose was robust, a new survey published in Nature Medicine ...

Drug shortages in America are the result of supply line challenges, profit-based operations, and company closures.

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...

Fears voiced that agreement could mean vaccines being taken from where they are most needed and sent to areas not at risk ...

Pfizer’s first-quarter revenue and earnings were down by nearly a third from a year ago on plummeting demand for its Covid-19 vaccine ... delivered its final supply for the U.S. government ...

The global Vaccine market has experienced a period of significant transformation, driven by a junction of factors. Valued at ...

Ventura County responded quickly and effectively to the COVID-19 pandemic but struggled at times to find protective equipment ...

opens new tab said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The move is in line ...

Gilead said it still expects product sales of $27.1 billion to $27.5 billion, but lowered its earnings outlook to include the recent charge as well as incremental expenses related to the CymaBay deal.

Detailed price information for Alliance Resource Pt (ARLP-Q) from The Globe and Mail including charting and trades.